How does circVec technology compare to conventional mRNA expression?
Drug Discovery World
JULY 3, 2024
This is a clear demonstration of a substantial, and statistically significant, advantage over mRNA-based expression. As a result, the data provides an important proof-of-concept for Circio’s circular RNA platform, which we expect will translate into improved gene therapies for patients in the future,” said Dr Thomas Hansen, CTO at Circio. “In
Let's personalize your content